Skip to content

Global Health Partnerships: The Pharmaceutical Industry and BRICA
Stock Photo: Cover May Be Different

Global Health Partnerships: The Pharmaceutical Industry and BRICA Hardcover - 2008

by Wang, Mei-Ling

  • Used
  • Good
  • Hardcover
Drop Ship Order

Description

hardcover. Good. Access codes and supplements are not guaranteed with used items. May be an ex-library book.
Used - Good
NZ$100.95
FREE Shipping to USA Standard delivery: 7 to 14 days
More Shipping Options
Ships from Bonita (California, United States)

Details

  • Title Global Health Partnerships: The Pharmaceutical Industry and BRICA
  • Author Wang, Mei-Ling
  • Binding Hardcover
  • Condition Used - Good
  • Pages 193
  • Volumes 1
  • Language ENG
  • Publisher Palgrave MacMillan
  • Date 2008-11-28
  • Features Bibliography, Dust Cover, Index, Table of Contents
  • Bookseller's Inventory # 0230515606.G
  • ISBN 9780230515604 / 0230515606
  • Weight 0.8 lbs (0.36 kg)
  • Dimensions 8.6 x 5.6 x 0.9 in (21.84 x 14.22 x 2.29 cm)
  • Library of Congress subjects Pharmaceutical industry, World health
  • Library of Congress Catalog Number 2008041055
  • Dewey Decimal Code 362.178

About Bonita California, United States

Biblio member since 2020
Seller rating: This seller has earned a 5 of 5 Stars rating from Biblio customers.

Terms of Sale: 30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

Browse books from Bonita

From the publisher

The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never been more urgent. The decrease of profits in pharmaceutical markets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India, China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnership model between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.

About the author

MEI LING WANG is Associate Professor of Social Sciences and Health Policy at the University of the Sciences in Philadelphia, USA, and studied at the Harvard School of Public Health. She has devoted her career to writing on global issues and has made more than 60 presentations in national and global meetings. She is also Chair of the Global Health Committee, Global Interdependence Centre.